The 4 Stages of Arsenic Poisoning Explained

What are the primary clinical symptoms associated with acute arsenic toxicity?

Acute arsenic toxicity manifests as a rapid, multisystem collapse driven by the disruption of cellular energy production and direct mucosal irritation.

• Vomiting is often the earliest sign, frequently accompanied by intense abdominal pain and profuse, watery diarrhea that quickly leads to severe dehydration.
• Hypotension develops as the cardiovascular system fails, resulting in a dangerously low blood pressure that requires aggressive fluid resuscitation.
• Encephalopathy presents as altered mental status, seizures, or coma, signaling that the toxin has crossed the blood-brain barrier to damage the central nervous system.
• Arrhythmias like QT prolongation are common, often visible on an electrocardiogram as the heart muscle struggles with metabolic instability.

How does the mechanism of action of arsenic disrupt cellular respiration?

Arsenic disrupts cellular respiration by inhibiting the pyruvate dehydrogenase complex, which effectively halts the conversion of pyruvate to acetyl-CoA and starves the Krebs cycle of fuel. It also mimics phosphate, uncoupling oxidative phosphorylation and preventing the production of adenosine triphosphate. A lot of people assume that arsenic targets the lungs first because it is a toxic gas in some industrial forms, but the primary damage is metabolic and systemic, occurring at the level of the individual cell's mitochondria regardless of the route of entry.

What are the common environmental and occupational sources of inorganic arsenic exposure?

Exposure often occurs through contaminated groundwater, which remains a significant public health concern in regions like Bangladesh where tube wells exceed the 10 parts per billion limit. Occupational risks include working with semiconductor manufacturing, wood preservation, or smelting processes where inorganic arsenic compounds are handled without proper containment.

How is chronic arsenic poisoning differentiated from acute exposure in a clinical setting?

Chronic arsenic poisoning is characterized by a slow, progressive accumulation of systemic damage that lacks the dramatic, sudden onset of acute toxicity.

• Hyperkeratosis of the palms and soles is a classic indicator, manifesting as hardened, wart-like growths that appear after years of low-level ingestion.
• Hyperpigmentation often presents as a "raindrop" pattern on the torso, where dark spots of skin contrast with areas of lighter, depigmented tissue.
• Peripheral neuropathy typically involves a symmetrical "stocking-glove" numbness or tingling, reflecting the gradual degradation of sensory and motor nerve fibers.
• Malignancies such as skin, bladder, or lung cancer may emerge decades later, as the body fails to repair DNA damage caused by long-term exposure.

What diagnostic tests are used to measure arsenic levels in the human body?

Clinicians primarily rely on 24-hour urine collections to assess recent exposure, as arsenic is rapidly cleared from the blood. Blood tests are generally only useful within a few hours of acute ingestion, as levels drop below detectable limits within 24 to 48 hours.

What are the standard medical treatments and chelating agents used to manage arsenic ingestion?

Treatment centers on aggressive supportive care, primarily focusing on fluid replacement to manage the profound losses from gastroenteritis. Once the patient is stabilized, chelation therapy is initiated to bind the arsenic and facilitate its excretion. Dimercaprol, also known as British Anti-Lewisite, is the traditional intramuscular agent used for severe cases, though it carries a risk of significant side effects like hypertension and fever.

Succimer, or dimercaptosuccinic acid, is frequently preferred for its oral availability and better safety profile in less critical situations. One nuance is that chelation must be started as soon as possible, as the efficacy of these agents drops significantly once the arsenic has moved from the bloodstream into the intracellular space or tissues.

What are the long-term dermatological and systemic health consequences of prolonged arsenic intake?

Prolonged intake leads to distinct dermatological changes and an increased risk of systemic organ dysfunction over several years of exposure.

Use these statistics to monitor patients who present with unexplained skin lesions or chronic cardiovascular issues in regions with known water contamination.

How does arsenic metabolism and excretion occur within the liver and kidneys?

The liver acts as the primary site for the detoxification of inorganic arsenic through a process of methylation. Enzymes convert inorganic arsenic into monomethylarsonic acid and dimethylarsinic acid, which are generally considered less toxic and more easily excreted. This metabolic pathway is essential for reducing the immediate impact of the toxin on sensitive tissues throughout the body.

The kidneys then handle the clearance of these methylated metabolites from the bloodstream into the urine. While this process is efficient for most, the rate of methylation varies significantly between individuals due to genetic differences in enzyme activity. One important nuance is that if renal function is already compromised, the body cannot effectively clear these arsenic metabolites, which leads to a dangerous accumulation and secondary systemic toxicity.